Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx-Reference-Cited by-同舟云学术

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx

Published:2001-07 Issue:7 Volume:15 Page:1123-1126
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Ribrag V,Hajj MEll,Janot F,Girinsky T,Domenge C,Schwaab G,Fenaux P,Bosq J

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2402148.pdf

Reference12 articles.

1. Cheung MMC, Chan JKC, Lau WH, Foo W, Chan PTM, Ng CS, Ngan RKC . Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype and treatment outcome in 113 patients J Clin Oncol 1998 16: 70–77

2. Ferry J, Sklar J, Zukerberg LR, Harris NL . Nasal lymphoma. A clinicopathologic study with immunophenotype and genotypic analysis Am J Surg Pathol 1991 15: 268–279

3. Kwong YL, Chan ACL, Liang RHS . Natural killer lymphoma/leukemia pathology and treatment Hematol Oncol 1997 15: 71–79

4. Kanavaros P, Lescs M-L, Brière J, Divine M, Galateau F, Joab I, Bosq J, Farcet J-P, Reyes F, Gaulard P . Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein–Barr virus Blood 1993 81: 2688–2695

5. Emile J-F, Boulland M-L, Haioun C, Kanavaros P, Petrella T, Delfau-Larue M-H, Bensussan A, Farcet J-P, Gaulard P . CD5−CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas Blood 1996 87: 1466–1473

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nasal-Type Natural Killer/T-cell Lymphoma With Inaugural Testicular Presentation in a Young Patient;Cureus;2024-02-22

2. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors;International Forum of Allergy & Rhinology;2024-01-02

3. A phase II study of sintilimab, anlotinib, and pegaspargase sandwiched with radiotherapy as first‐line therapy in patients with newly diagnosed, stage I–II extranodal natural‐killer/T‐cell lymphoma;American Journal of Hematology;2023-04-07

4. Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study;British Journal of Haematology;2023-02-17

5. Progress of Hematopoietic Stem Cell Transplantation and Radiotherapy in the Treatment of Extranodal NK/T Cell Lymphoma;Frontiers in Oncology;2022-02-16